Literature DB >> 23322468

Carotid plaque characteristics and disease activity in rheumatoid arthritis.

Anne G Semb1, Silvia Rollefstad, Sella A Provan, Tore K Kvien, Einar Stranden, Inge C Olsen, Jonny Hisdal.   

Abstract

OBJECTIVE: Carotid plaques (CP) are predictive of acute coronary syndrome in patients with rheumatoid arthritis (RA), suggesting that atherosclerotic plaques in these patients are vulnerable. The objective of our study was to characterize vulnerability of CP in patients with RA compared to a control population, and between RA patients with different levels of disease activity.
METHODS: Ultrasound examination of carotid arteries was performed in 152 patients with RA and 89 controls. CP echolucency was evaluated by the Gray-Scale Median (GSM) technique. Lower GSM values indicate higher vulnerability of plaques. CP characteristics were compared between RA patients with active disease and in remission, and between patients and controls. All analyses were performed with adjustment for confounding factors (sex, age, smoking, and blood pressure). Poisson regression analysis was used for count data, mixed modeling for GSM and area per plaque, and analysis of covariance for minimum GSM value per patient.
RESULTS: Patients with RA more frequently had CP (median 2, range 0, 4) compared with controls (median 1, range 0, 3; p < 0.001), after adjustment for age and sex. Patients with active RA disease according to the Clinical Disease Activity Index (CDAI) had lower median GSM (p = 0.03), minimum GSM (p = 0.03), and a larger CP area (although the latter finding was not significant; p = 0.27), compared with patients with RA in remission. These findings were not confirmed for other disease measures (Simplified Disease Activity Index, Disease Activity Score-28, C-reactive protein, erythrocyte sedimentation rate).
CONCLUSION: Patients with RA had more CP compared with controls and patients in CDAI remission, and controls had more stable CP than patients with active disease; these findings point to the importance of achieving remission in RA.

Entities:  

Mesh:

Year:  2013        PMID: 23322468     DOI: 10.3899/jrheum.120621

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  24 in total

1.  The role of rheumatoid arthritis (RA) flare and cumulative burden of RA severity in the risk of cardiovascular disease.

Authors:  Elena Myasoedova; Arun Chandran; Birkan Ilhan; Brittny T Major; C John Michet; Eric L Matteson; Cynthia S Crowson
Journal:  Ann Rheum Dis       Date:  2015-01-30       Impact factor: 19.103

Review 2.  Managing premature atherosclerosis in patients with chronic inflammatory diseases.

Authors:  Alexandra Legge; John G Hanly
Journal:  CMAJ       Date:  2018-04-09       Impact factor: 8.262

3.  Outcomes of acute cardiovascular events in rheumatoid arthritis and systemic lupus erythematosus: a population-based study.

Authors:  Chao-Han Lai; Cheng-Yang Hsieh; April Barnado; Li-Ching Huang; Sheau-Chiann Chen; Liang-Miin Tsai; Yu Shyr; Chung-Yi Li
Journal:  Rheumatology (Oxford)       Date:  2020-06-01       Impact factor: 7.580

4.  Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis.

Authors:  Cynthia S Crowson; Silvia Rollefstad; Eirik Ikdahl; George D Kitas; Piet L C M van Riel; Sherine E Gabriel; Eric L Matteson; Tore K Kvien; Karen Douglas; Aamer Sandoo; Elke Arts; Solveig Wållberg-Jonsson; Lena Innala; George Karpouzas; Patrick H Dessein; Linda Tsang; Hani El-Gabalawy; Carol Hitchon; Virginia Pascual Ramos; Irazú Contreras Yáñez; Petros P Sfikakis; Evangelia Zampeli; Miguel A Gonzalez-Gay; Alfonso Corrales; Mart van de Laar; Harald E Vonkeman; Inger Meek; Anne Grete Semb
Journal:  Ann Rheum Dis       Date:  2017-09-06       Impact factor: 19.103

Review 5.  Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions.

Authors:  Justin C Mason; Peter Libby
Journal:  Eur Heart J       Date:  2014-11-27       Impact factor: 29.983

Review 6.  Cardiovascular risk in patients with rheumatoid arthritis.

Authors:  Kim Lauper; Cem Gabay
Journal:  Semin Immunopathol       Date:  2017-04-28       Impact factor: 9.623

Review 7.  Cardiovascular comorbidity in rheumatic diseases.

Authors:  Michael T Nurmohamed; Maaike Heslinga; George D Kitas
Journal:  Nat Rev Rheumatol       Date:  2015-08-18       Impact factor: 20.543

Review 8.  Atherosclerosis in rheumatoid arthritis: is it all about inflammation?

Authors:  Sarah Skeoch; Ian N Bruce
Journal:  Nat Rev Rheumatol       Date:  2015-03-31       Impact factor: 20.543

9.  SMAD3 rs17228212 gene polymorphism is associated with reduced risk to cerebrovascular accidents and subclinical atherosclerosis in anti-CCP negative Spanish rheumatoid arthritis patients.

Authors:  Mercedes García-Bermúdez; Raquel López-Mejías; Fernanda Genre; Santos Castañeda; Carlos González-Juanatey; Javier Llorca; Alfonso Corrales; José A Miranda-Filloy; Javier Rueda-Gotor; Carmen Gómez-Vaquero; Luis Rodríguez-Rodríguez; Benjamín Fernández-Gutiérrez; Dora Pascual-Salcedo; Alejandro Balsa; Francisco J López-Longo; Patricia Carreira; Ricardo Blanco; Isidoro González-Álvaro; Javier Martín; Miguel A González-Gay
Journal:  PLoS One       Date:  2013-10-21       Impact factor: 3.240

10.  Rosuvastatin improves endothelial function in patients with inflammatory joint diseases, longitudinal associations with atherosclerosis and arteriosclerosis: results from the RORA-AS statin intervention study.

Authors:  Eirik Ikdahl; Jonny Hisdal; Silvia Rollefstad; Inge C Olsen; Tore K Kvien; Terje R Pedersen; Anne Grete Semb
Journal:  Arthritis Res Ther       Date:  2015-10-08       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.